Skip to search boxSkip to navigationSkip to main content

rhBMP-2 significantly enhances guided bone regeneration

  • Ulf M E Wikesjö(corresponding author)
    ,
  • Mohammed Qahash
    ,
  • Robert C. Thomson
    ,
  • Alonzo D. Cook
    ,
  • Michael D. Rohrer
    ,
  • John M. Wozney
*Corresponding author for this work
  • Temple University
    ,
  • W.L. Gore & Associates, Inc.
    ,
  • University of Minnesota Twin Cities
    ,
  • Wyeth
    ,
  • ,
  • Pfizer
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Background: Previous studies have shown a limited potential for bone augmentation following guided bone regeneration (GBR) in horizontal alveolar defects. Surgical implantation of recombinant human bone morphogenetic protein-2 (rhBMP-2) in an absorbable collagen sponge carrier (ACS) significantly enhances bone regeneration in such defects; however, sufficient quantities of bone for implant dentistry are not routinely obtained. The objective of this study was to evaluate the potential of rhBMP-2/ACS to enhance GBR using a space-providing, macro-porous expanded polytetraf luoroethylene (ePTFE) device. Methods: Bilateral, critical size, supra-alveolar, peri-implant defects were surgically created in four Hound Labrador mongrel dogs. Two turned and one surface-etched 10-mm titanium dental implant were placed 5 mm into the surgically reduced alveolar ridge creating 5-mm supra-alveolar defects. rhBMP-2/ACS (rhBMP-2 at 0.2 mg/ml) or buffer/ACS was randomly assigned to left and right jaw quadrants in subsequent animals. The space-providing, macroporous ePTFE device was placed to cover rhBMP-2/ACS and control constructs and dental implants. Gingival flaps were advanced for primary wound closure. The animals were euthanized at 8 weeks postsurgery for histologic and histometric analysis. Results: Bone formation was significantly enhanced in defects receiving rhBMP-2/ACS compared to control. Vertical bone gain averaged (± SD) 4.7 ± 0.3 and 4.8 ± 0.1 mm, and new bone area 10.3 ± 2.0 and 8.0 ± 2.5 mm2 at turned and surface-etched dental implants, respectively. Corresponding values for the control were 1.8 ± 2.0 and 1.3 ± 1.3 mm, and 1.8 ± 1.3 and 1.2 ± 0.6 mm2. Bone-implant contact in rhBMP-2-induced bone averaged 6.4 ± 1.4% and 9.6 ± 7.5% for turned and surface-etched dental implants, respectively (P = 0.399). Corresponding values for the control were 14.6 ± 19.4% and 23.7 ± 9.7% (P = 0.473). Bone-implant contact in resident bone ranged between 43% and 58% without significant differences between dental implant surfaces. Conclusions: rhBMP-2/ACS significantly enhances GBR at turned and surface-etched dental implants. The dental implant surface technology does not appear to substantially influence bone formation.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 194-204 (11 pages)

Journal (Volume, Issue Number)

Clinical Oral Implants Research (Volume 15, Issue 2)

Publication milestones

  • Published - 04/2004

Publication status

Published - 04/2004

ISSN

0905-7161

Publication IDs

  • Scopus: 2942655267
  • PubMed: 15008931

Publication metrics

Metrics

Scopus
citations
SciVal
citations
98
SciVal
FWCI
3.18
SciVal
Author count
7
SciVal
Paper percentile
94
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
111
Captures
115